Effect of Lanostane Triterpenes from the Fruiting Bodies of Ganoderma lucidum on Adipocyte Differentiation in 3T3-L1 Cells

 

 Buy Article Permissions and Reprints

Abstract

Two new lanostane triterpenes, methyl lucidenate N (1) and t-butyl lucidenate B (2), were isolated from the fruiting bodies of Ganoderma lucidum together with five known compounds (3–7). The structures of the two new triterpenes were established as methyl 3β,7β-dihydroxy-4,4,14α-trimethyl-11,15-dioxo-5α-chol-8-en-24-oate (1) and t-butyl 7β,12β-dihydroxy-4,4,14α-trimethyl-3,11,15-trioxo-5α-chol-8-en-24-oate (2) by extensive spectroscopic studies and chemical evidence. The effect of the isolated compounds (1–7) on triglyceride (TG) accumulation, an indicator of adipocyte differentiation, during the differentiation of 3T3-L1 preadipocytes was examined. t-Butyl lucidenate B (2) reduced the TG accumulation significantly by 72 % at 80 µM compared to the untreated group. Furthermore, compound 2 effectively suppressed the GPDH activity in the cells. Consistent with the decrease in TG accumulation and GPDH activity, compound 2 suppressed the gene expressions of PPARγ, C/EBPα, and SREBP-1c in a dose-dependent manner during differentiation. Our findings demonstrate that the lanostane triterpenes isolated in this study contribute to the inhibitory effect of the fruiting bodies of G. lucidum on adipocyte differentiation in 3T3-L1 cells.

References

• 1 Furuyashiki T, Nagayasu H, Aoki Y, Bessho H, Hashimoto T, Kanazawa K. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ2 and C/EBPα in 3T3-L1 cells.  Biosci Biotechnol Biochem. 2004;  68 2353-2359
  CrossrefPubMedGoogle Scholar
• 2 Han L K, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea.  Int J Obes Relat Metab Disord. 1999;  23 98-105
  CrossrefPubMedGoogle Scholar
• 3 Hsu C L, Yev G C. Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 Cells.  J Agric Food Chem. 2007;  55 1730-1736
  CrossrefPubMedGoogle Scholar
• 4 Hsu C L, Yev G C. Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes.  J Agric Food Chem. 2007;  55 8404-8410
  CrossrefPubMedGoogle Scholar
• 5 Liu D Z, Wang F, Liao T G, Tang J G, Steglich W, Zhu H J, Liu J K. Vibralactone: a lipase inhibitor with an unusual fused β-lactone produced by cultures of the basidiomycete Boreostereum vibrans.  Org Lett. 2006;  8 5749-5752
  CrossrefPubMedGoogle Scholar
• 6 Min B S, Nakamura N, Miyashiro H, Bae K W, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease.  Chem Pharm Bull. 1998;  46 1607-1612
  PubMedGoogle Scholar
• 7 Kimura S, Tamura T J. Dietary effects of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypotensive rats (SHR).  Nutr Sci Vitam. 1988;  34 433-438
  PubMedGoogle Scholar
• 8 Kim D H, Shim S B, Kim N J, Jang J S. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum.  Biol Pharm Bull. 1999;  22 162-164
  PubMedGoogle Scholar
• 9 Toth J O, Luu B, Ourision G. Les acides ganoderiques T & Z, triterpens cytotoxiques de Ganoderma lucidum (Polyporaceae).  Tetrahedron Lett. 1983;  24 1081-1084
  CrossrefPubMedGoogle Scholar
• 10 Tasaka K, Mio M, Isushi K, Akagi M, Mikino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum (II). The inhibitory effect of cyclooctasulfur on histamine release.  Agents Actions. 1988;  23 157-160
  CrossrefPubMedGoogle Scholar
• 11 Komoda Y, Shimizu M, Sonoda Y, Sato Y. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.  Chem Pharm Bull. 1990;  38 1359-1364
  PubMedGoogle Scholar
• 12 Lee C W, Yoon H M, Kang K H. Adipocyte-related genes and transcription factors were affected by Ganoderma lucidum during 3T3-L1 differentiation.  J Korean Inst Herbal Acupunct. 2009;  12 213-220
  PubMedGoogle Scholar
• 13 Wu T S, Shi L S, Kuo S C. Cytotoxicity of Ganoderma lucidum triterpenes.  J Nat Prod. 2001;  64 1121-1122
  CrossrefPubMedGoogle Scholar
• 14 Nishitoba T, Sato H, Kasai T, Kawagishi H, Sakamura S. New bitter C₂₇ and C₃₀ terpenoids from the fungus Ganoderma lucidum (Reishi).  Agric Biol Chem. 1985;  49 1793-1798
  PubMedGoogle Scholar
• 15 Iwatsuki K, Akihisa T, Tokuda H, Ukiya M, Oshikubo M, Kimura Y, Asano T, Nomura A, Nishino H. Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation.  J Nat Prod. 2003;  66 1582-1585
  CrossrefPubMedGoogle Scholar
• 16 Kikuchi T, Kanomi S, Murai Y, Kadota S, Tsubono K, Ogita Z I. Constituents of the fungus Ganoderma lucidum (FR.) Karst. II. Structures of ganoderic acids F, G, and H, lucidenic acids D2 and E2, and related compounds.  Chem Pharm Bull. 1986;  34 4018-4029
  PubMedGoogle Scholar
• 17 Wise L S, Green H. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells.  J Biol Chem. 1979;  254 273-275
  PubMedGoogle Scholar
• 18 Rosen E D, Walkey C J, Puigserver P, Spiegelman B M. Transcriptional regulation of adipogenesis.  Genes Dev. 2000;  14 1293-1307
  PubMedGoogle Scholar
• 19 Kim J B, Spiegelman B M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.  Genes Dev. 1996;  10 1096-1107
  CrossrefPubMedGoogle Scholar
• 20 Soukas A, Cohen P, Socci N D, Friedman J M. Leptin-specific patterns of gene expression in white adipose tissue.  Genes Dev. 2000;  14 963-980
  PubMedGoogle Scholar

Prof. Dr. KiHwan Bae

College of Pharmacy
Chungnam National University

Daejeon 305-764

Korea

Phone: + 82 4 28 21 59 25

Fax: + 82 4 28 23 65 66

Email: baekh@cnu.ac.kr

• Supplementary Material